Vasa Denticity (NSE:DENTALKART) EBIT: ₹77 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:DENTALKART Vasa Denticity Ltd NSE:DENTALKART
75 GF Score
Price ₹408.55
GF Value ₹954.79
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Vasa Denticity EBIT?

Vasa Denticity NSE:DENTALKART +3.75% 75 EBIT is ₹77 Mil as of Mar. 2026. GuruFocus rates NSE:DENTALKART with a GF Score™ of 75/100 and a GF Value™ of ₹954.79 (Possible Value Trap). The stock has 6 warning signs investors should review.

Vasa Denticity's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₹16 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹77 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Vasa Denticity's annualized ROC % for the quarter that ended in Mar. 2026 was -0.99%. Vasa Denticity's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 6.68%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Vasa Denticity's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 1.26%.

Vasa Denticity  (NSE:DENTALKART) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Vasa Denticity's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-16.584 * ( 1 - 21.65% )/( (1262.726 + 1361.217)/ 2 )
=-12.993564/1311.9715
=-0.99 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1913.28 - 118.582 - ( 531.972 - max(0, 186.825 - 1624.854+531.972))
=1262.726

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1973.689 - 139.78 - ( 472.692 - max(0, 208.946 - 1673.87+472.692))
=1361.217

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Vasa Denticity's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=64.86/( ( (150.149 + max(800.782, 0)) + (183.188 + max(808.488, 0)) )/ 2 )
=64.86/( ( 950.931 + 991.676 )/ 2 )
=64.86/971.3035
=6.68 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(176.354 + 753.218 + 58.035) - (118.582 + 0 + 68.243)
=800.782

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(120.511 + 811.574 + 84.144) - (139.78 + 0 + 67.961)
=808.488

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Vasa Denticity's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=76.694/6085.955
=1.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vasa Denticity EBIT Related Terms

Vasa Denticity EBIT Historical Data

* Premium members only.

The historical data trend for Vasa Denticity's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vasa Denticity EBIT Chart

Vasa Denticity Annual Data
Trend Mar20 Mar21 Mar22 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial 4.96 57.75 194.85 231.30 133.13

Vasa Denticity Quarterly Data
Mar20 Mar21 Mar22 Dec22 Sep23 Dec23 Mar24 Sep24 Dec24 Mar25 Sep25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.89 54.81 59.91 60.48 16.22

NSE:DENTALKART vs MCK, COR, CAH: EBIT Comparison

For the Medical Distribution subindustry, Vasa Denticity's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vasa Denticity EV-to-EBIT vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Vasa Denticity's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Vasa Denticity's EV-to-EBIT falls into.


NSE:DENTALKART
75GF Score
Vasa Denticity Ltd NSE:DENTALKART
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vasa Denticity EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹77 Mil mean?
Vasa Denticity (NSE:DENTALKART) has a EBIT of ₹77 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Vasa Denticity.
Is Vasa Denticity's EBIT too high?
Vasa Denticity's current EBIT is ₹77 Mil. Overall, Vasa Denticity has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vasa Denticity's EBIT compare to MCK and COR?
Vasa Denticity's EBIT of ₹77 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Distribution company?
A good EBIT depends on the Medical Distribution industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Vasa Denticity. Vasa Denticity's current EBIT is ₹77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vasa Denticity stock overvalued right now?
Based on GuruFocus' analysis, Vasa Denticity (NSE:DENTALKART) is currently considered Possible Value Trap. The stock's GF Value™ is ₹954.79, compared to a current price of ₹408.55 — trading 57.2% below its estimated fair value. The current EBIT is ₹77 Mil. Vasa Denticity's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Vasa Denticity (NSE:DENTALKART), the current EBIT is ₹77 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vasa Denticity (NSE:DENTALKART) Overvalued in 2026?

Based on GuruFocus' analysis, Vasa Denticity stock appears to be undervalued. The current stock price of ₹408.55 is trading 57.2% below its estimated GF Value™ of ₹954.79. GuruFocus considers Vasa Denticity to be Possible Value Trap.

Key valuation signals for NSE:DENTALKART:

  • EBIT: ₹77 Mil
  • GF Value™: ₹954.79 vs. price of ₹408.55 (57.2% below fair value)
  • GF Score™: 75/100 with 6 warning signs

No single metric tells the full story. See the NSE:DENTALKART stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vasa Denticity Business Description

Address Village, P.O. Chattarpur, Khasra No. 714, South Delhi, New Delhi, IND, 110074
Vasa Denticity Ltd is engaged in marketing and distributing a comprehensive portfolio of dental products, including consumables, instruments, equipment, and accessories for diagnosing, treating, and preventing dental conditions, as well as improving the aesthetics of the human smile through the online portal Dentalkart.com. The company's products include instruments, disinfectant tools, sterilizing equipment, impression materials, temporary materials for tooth filling, and others.
75GF Score

Get the complete analysis for NSE:DENTALKART

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹408.55
Price
₹954.79
GF Value